Fasting insulin levels significantly decreased with tirzepatide (10 mg and 15 mg), and HOMA2-IR, a measure of insulin resistance, significantly decreased with tirzepatide (10 mg) compared to both placebo and dulaglutide
Diarrhea Diarrhea is less common than constipation but still affects 5%25% of patients, most often in the first few weeks of therapy
Assess risk factors : Do you have type 2 diabetes
By combining GLP-1 therapy with lifestyle changes, such as regular exercise and a balanced diet, we help our patients achieve their health goals safely and effectively
Higher levels of the glycoprotein promote fibrin formation, increasing a persons clot risk
Initial results of the Phase 3 ESSENCE trial looking at the effect of semaglutide on liver disease were released at the November 2024 American Association for the Study of Liver Diseases meeting